Erratum to: Am J Cardiovasc Drugs DOI 10.1007/s40256-015-0156-x {#Sec1}
===============================================================

Errors have subsequently been identified in the original publication, and the following corrections should be noted:

Abstract, Results section, lines 9--11 which previously read:

After 8 weeks of double-blind treatment, the changes in msDBP were −9.50 (8.46) mmHg in the OM/AML/HCTZ group and −4.23 (7.41) mmHg in the OM/HCTZ group (both *p* \< 0.0001 vs. baseline; *p* \< 0.0001 between groups).

Should read:

After 8 weeks of double-blind treatment, the changes in msDBP were −11.39 (8.34) mmHg in the OM/AML/HCTZ group and −5.74 (9.22) mmHg in the OM/HCTZ group (both *p* \< 0.0001 vs. baseline; *p* \< 0.0001 between groups).

Results, Section 3.2 Efficacy, para 1, lines 2--3 which previously read:

After 8 weeks of double-blind treatment, the changes in msDBP were −9.50 (8.46) mmHg in the OM/AML/HCTZ group and −4.23 (7.41) mmHg in the OM/HCTZ group (both *p* \< 0.0001 vs. baseline; *p* \< 0.0001 between groups; Fig. 2a).

Should read:

After 8 weeks of double-blind treatment, the changes in msDBP were −11.39 (8.34) mmHg in the OM/AML/HCTZ group and −5.74 (9.22) mmHg in the OM/HCTZ group (both *p* \< 0.0001 vs. baseline; *p* \< 0.0001 between groups; Fig. 2a).

Results, Section 3.2 Efficacy, para 2, lines 2--5 which previously read:

The changes in msDBP and msSBP from randomization to after 4 weeks of treatment were −11.39 (8.34) mmHg and −14.75 (12.50) mmHg, respectively, in the OM/AML/HCTZ group (both *p* \< 0.0001 vs. baseline) and −5.74 (9.22) mmHg and −7.93 (11.99) mmHg, respectively, in the OM/HCTZ group (both *p* \< 0.0001 vs. baseline; both *p* \< 0.0001 between groups; Fig. 2).

Should read:

...The changes in msDBP and msSBP from randomization to after 4 weeks of treatment were −9.50 (8.46) mmHg and −14.75 (12.50) mmHg, respectively, in the OM/AML/HCTZ group (both *p* \< 0.0001 vs. baseline) and −4.23 (7.41) mmHg and −7.93 (11.99) mmHg, respectively, in the OM/HCTZ group (both *p* \< 0.0001 vs. baseline; both *p* \< 0.0001 between groups; Fig. 2).

The online version of the original article can be found under doi:10.1007/s40256-015-0156-x.
